
Commentary|Slideshows|April 10, 2026
Molecular Imaging in Focus Series: The First Three Episodes
Author(s)Diagnostic Imaging Staff
Catch up on the first three episodes of our Molecular Imaging in Focus series featuring interviews with Gary Ulaner, MD, PhD, Louise Emmett, MBChB, FRACP, FAANMS, MD, and Jeremie Calais, MD, PhD.
Advertisement
We take a look back at the first three episodes of our new Molecular Imaging in Focus series with topics ranging from the potential of the emerging radiodiagnostic agent 61Cu-NU101 and recent findings from the Co-PSMA trial with 64Cu-SAR-bisPSMA to the utility of PSMA PET in risk stratification for patients with prostate cancer. Review the slideshow below to watch the first three episodes.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging PET Radiotracer May Enhance Detection of Small Metastases in Patients with Advanced Melanoma
2
Can Biomechanical CT Have an Impact in Opportunistic Screening for Osteoporosis?
3
Can Photon-Counting CT Provide Timely Clarity After Mechanical Thrombectomy?
4
What a Meta-Analysis Reveals About FAPI PET/CT for Detection of Peritoneal Metastases
5















